Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BREWER J. I., SMITH R. T., PRATT G. B. Choriocarcinoma. Absolute 5 year survival rates of 122 patients treated by hysterectomy. Am J Obstet Gynecol. 1963 Apr 1;85:841–843. doi: 10.1016/s0002-9378(16)35583-1. [DOI] [PubMed] [Google Scholar]
- Hertz R., Ross G. T., Lipsett M. B. Chemotherapy in women with trophoblastic disease: choriocarcinoma, chorioadenoma destruens, and complicated hydatidiform mole. Ann N Y Acad Sci. 1964 Apr 2;114(2):881–885. [PubMed] [Google Scholar]
- LI M. C., HERTZ R., BERGENSTAL D. M. Therapy of choriocarcinoma and related trophoblastic tumors with folic acid and purine antagonists. N Engl J Med. 1958 Jul 10;259(2):66–74. doi: 10.1056/NEJM195807102590204. [DOI] [PubMed] [Google Scholar]
- PECK H. M., WOODHOUR A. F., METZGAR D. P., MCKINNEY S. E., HILLEMAN M. R. NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. 2. SHORT-TERM ANIMAL TOXICITY TESTS. Proc Soc Exp Biol Med. 1964 Jun;116:523–530. doi: 10.3181/00379727-116-29296. [DOI] [PubMed] [Google Scholar]
- WOODHOUR A. F., METZGAR D. P., STIM T. B., TYTELL A. A., HILLEMAN M. R. NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. I. DEVELOPMENT AND ANIMAL IMMUNE RESPONSE. Proc Soc Exp Biol Med. 1964 Jun;116:516–523. doi: 10.3181/00379727-116-29295. [DOI] [PubMed] [Google Scholar]